Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases/Experiment 2/Signature 1
From BugSigDB
Source: Fig-3c
Description: Log2FC of species that represented significant change at week 14 follow-up in comparison with baseline sample of CD divided into remission and non-remission groups
Abundance in Group 1: decreased abundance in Remitters Crohn's disease (CD)
NCBI | Quality Control | Links |
---|---|---|
Bifidobacterium longum | ||
Eggerthella | ||
Mediterraneibacter gnavus | ||
Roseburia inulinivorans | ||
Veillonella parvula |